Heath Lukatch, Director at Vaxcyte, Inc. (PCVX), sold 315 shares at $46.33 ($15K) on 2023-01-10, disclosed to the SEC on 2023-01-12.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.04 | 233 | $11K | 73.8% |
| 2 | $46.33 | 82 | $4K | 26.2% |
| Total | $46.12 avg | 315 | $15K | 100% |
| Filing → |
| PCVX | SELL | 2024-01-04 | $1.6M | — | Filing → |
| PCVX | SELL | 2022-12-14 | $15K | — | Filing → |
| PCVX | SELL | 2022-11-15 | $200K | — | Filing → |